Recent ALGS News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/26/2024 08:15:28 PM
- Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer • GlobeNewswire Inc. • 09/24/2024 12:00:00 PM
- Aligos Therapeutics Announces Positive Topline Results from the Phase 2a HERALD Study of ALG-055009 for the Treatment of MASH • GlobeNewswire Inc. • 09/19/2024 12:00:00 PM
- Aligos Therapeutics to Announce Topline Results from the Phase 2a HERALD Study of ALG-055009 for the Treatment of MASH on September 19, 2024 • GlobeNewswire Inc. • 09/18/2024 09:00:00 PM
- Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/13/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2024 08:22:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 08:06:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 08:05:59 PM
- Aligos Therapeutics Announces Reverse Stock Split • GlobeNewswire Inc. • 08/15/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 08:09:21 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 08:08:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:11:01 PM
- Aligos Therapeutics Strengthens Board with Two New Independent Directors • GlobeNewswire Inc. • 08/08/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 08:14:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:05:31 PM
- Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/06/2024 08:05:00 PM
- Aligos Therapeutics to Announce 2nd Quarter 2024 Financial Results on August 6, 2024 • GlobeNewswire Inc. • 07/30/2024 08:05:00 PM
- Aligos Therapeutics Announces Clinical Collaboration with Xiamen Amoytop Biotech Co., Ltd. • GlobeNewswire Inc. • 07/22/2024 01:00:00 PM
- Aligos Therapeutics to Host KOL Event to Discuss the Positive Phase 1b Data from ALG-000184 for the Treatment of CHB • GlobeNewswire Inc. • 07/10/2024 12:00:00 PM
- Aligos Therapeutics Presents Positive Data at the EASL Congress 2024 • GlobeNewswire Inc. • 06/05/2024 06:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 08:05:56 PM
- Aligos Therapeutics Announces Six Abstracts Accepted for Presentation at EASL 2024 • GlobeNewswire Inc. • 05/22/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:02:52 PM
- Aligos Therapeutics Announces the Completion of Enrollment in the ALG-055009 Phase 2a HERALD Study for the Treatment of MASH • GlobeNewswire Inc. • 05/21/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 09:01:03 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM